Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...

In a peer-reviewed article published today in Brain Medicine, a European research team presents a focused review of emerging neuromodulation techniques for treatment-resistant obsessive-compulsive ...

Toronto, Ontario – January 22, 2013 – Functional Neuromodulation, a company advancing the use of deep brain stimulation (DBS) for Alzheimer’s disease and other memory disorders, announced today the ...

Epilepsy is one of the most common neurological diseases, affecting around 50 million people worldwide, and carries a debilitating burden for the patient. It is characterized by recurrent seizures ...

The rising incidences of chronic pain, neurological disorders and mental health conditions continue to drive the demand for global neuromodulation devices. According to Grand View Research, the market ...